India · Delayed Price · Currency is INR Panacea Biotec Company Description
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally.
It operates through Vaccines and Formulations segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as transplantation, renal disease, oncology, respiratory, pain management, diabetes and cardiovascular management, gastro-intestinal care, nephrology, osteoporosis management, orthopedics, pain management, and fever; and betacoronavirus, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, hepatitis A, and varicella vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands.
In addition, the company engages in the real estate business. It exports its products to approximately 50 countries.
The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V; Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc for the manufacture and supply of Azacitidine injection; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine.
Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
| Country | India |
| Founded | 1984 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 1,936 |
Contact Details
Address: B-1 Extension/G-3 New Delhi, Punjab 110044 India | |
| Phone | 91 11 4167 9000 |
| Website | panaceabiotec.com |
Stock Details
| Ticker Symbol | 531349 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2836 |